EPIVAX THERAPEUTICS Trademark

Trademark Overview

On Friday, January 21, 2022, a trademark application was filed for EPIVAX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EPIVAX THERAPEUTICS trademark a serial number of 97231957. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, February 13, 2024. This trademark is owned by EpiVax, Inc.. The EPIVAX THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; Pharmaceutical research and development; Vaccine research and development
epivax therapeutics

General Information

Serial Number97231957
Word MarkEPIVAX THERAPEUTICS
Filing DateFriday, January 21, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, February 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development of vaccines and medicines; Pharmaceutical research and development; Vaccine research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 26, 2022
Primary Code042
First Use Anywhere DateFriday, February 26, 2021
First Use In Commerce DateFriday, February 26, 2021

Trademark Owner History

Party NameEpiVax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressProvidence, RI 02909
Party NameEpiVax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressProvidence, RI 02909

Trademark Events

Event DateEvent Description
Friday, February 16, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, February 14, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 13, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 8, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 18, 2024USE AMENDMENT FILED
Thursday, February 8, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 18, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, June 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 22, 2023SOU EXTENSION 1 GRANTED
Thursday, June 22, 2023SOU EXTENSION 1 FILED
Thursday, June 22, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 31, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 1, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2022NON-FINAL ACTION E-MAILED
Tuesday, November 1, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 1, 2022ASSIGNED TO EXAMINER
Wednesday, September 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 25, 2022NEW APPLICATION ENTERED

Related Keywords

therapeutics epivax research development vaccine pharmaceutical vaccines medicines